Strategies to optimize CAD prevention in modern cardiology - The "Marburg CAD Prevention Project"

被引:4
作者
Schaefer, JR [1 ]
Simon, B [1 ]
Soufi, M [1 ]
Sattler, A [1 ]
Noll, B [1 ]
Herzum, M [1 ]
Maisch, B [1 ]
机构
[1] Univ Hosp Marburg, Dept Internal Med & Cardiol, Marburg, Germany
关键词
CAD prevention; Marburg CAD Prevention Project; CARDDAS (R); deadly trias; low HDL; elevated Lp(a); elevated homocystein;
D O I
10.1007/PL00001948
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In recent years we identified numerous cardiovascular risk factors and had been able to reduce cardiovascular events by a variety of different interventions. There is no question that we can improve the course of coronary artery disease (CAD) in patients with a high-risk profile by modifying these factors. Despite this knowledge, many patients with known CAD or myocardial infarction are not treated for secondary prevention as recommended by well established guidelines (http://www.chd-taskforce.com). In order to improve secondary prevention in our patients we started a project, the so called "Marburg CAD Prevention Project". By this we combine our computer data base of the CAD preventional routine laboratory with the computer program CARDDAS(R). Individual risk factors and the angiographic findings were analyzed. Patients as well as local physicians were informed on the need to treat the important risk factors. This approach ensures that at least all of our patients with documented CAD receive the appropriate preventional recommendations and treatment.
引用
收藏
页码:113 / 116
页数:8
相关论文
共 16 条
[1]   Effect of HMGcoA reductase inhibitors on stroke - A meta-analysis of randomized, controlled trials [J].
Bucher, HC ;
Griffith, LE ;
Guyatt, GH .
ANNALS OF INTERNAL MEDICINE, 1998, 128 (02) :89-+
[2]   Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels - Results of AFCAPS/TexCAPS [J].
Downs, JR ;
Clearfield, M ;
Weis, S ;
Whitney, E ;
Shapiro, DR ;
Beere, PA ;
Langendorfer, A ;
Stein, EA ;
Kruyer, W ;
Gotto, AM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (20) :1615-1622
[3]  
Packard CJ, 1998, CIRCULATION, V97, P1440
[4]  
PEDERSEN TR, 1994, LANCET, V344, P1383
[5]   Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease - A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S) [J].
Pyorala, K ;
Pedersen, TR ;
Kjekshus, J ;
Faergeman, O ;
Olsson, AG ;
Thorgeirsson, G .
DIABETES CARE, 1997, 20 (04) :614-620
[6]  
Sacks FM, 1998, CIRCULATION, V97, P1446
[7]   The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels [J].
Sacks, FM ;
Pfeffer, MA ;
Moye, LA ;
Rouleau, JL ;
Rutherford, JD ;
Cole, TG ;
Brown, L ;
Warnica, JW ;
Arnold, JMO ;
Wun, CC ;
Davis, BR ;
Braunwald, E .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (14) :1001-1009
[8]  
Schaefer JR, 1999, HERZ, V24, P3, DOI 10.1007/BF03043813
[9]  
Schaefer JR, 1998, HERZ, V23, P153, DOI 10.1007/BF03044600
[10]  
SCHAEFER JR, 1998, PRAVENTIVE KARDIOLOG